Steve Carlin is a CMC Manager, Product Development in MSK’s Office of Entrepreneurship & Commercialization (OEC), where he provides early clinical development guidance, manufacturing process optimization, and regulatory submission support for the MSK product pipeline. Steve assumed this role in 2022.
Prior to joining OEC, Steve worked in radiopharmaceutical development and clinical manufacturing at different roles for over 10 years. He most recently served as a Clinical Radiochemist at MSK’s Radiochemistry & Molecular Imaging Probes core facility.
Steve holds Bachelor’s and Master’s degrees in Chemistry from Colby College and the University of Washington, respectively, and a Master’s degree in Economics from the City University of New York - John Jay College.